These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17096027)

  • 1. Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects.
    Zhang X; Yang Z; Dong L; Papageorgiou A; McConkey DJ; Benedict WF
    Cancer Gene Ther; 2007 Mar; 14(3):241-50. PubMed ID: 17096027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
    Benedict WF; Tao Z; Kim CS; Zhang X; Zhou JH; Adam L; McConkey DJ; Papageorgiou A; Munsell M; Philopena J; Engler H; Demers W; Maneval DC; Dinney CP; Connor RJ
    Mol Ther; 2004 Sep; 10(3):525-32. PubMed ID: 15336652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity.
    Zhang XQ; Yang Z; Benedict WF
    Cancer Gene Ther; 2011 Apr; 18(4):260-4. PubMed ID: 21183949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.
    Zhang XQ; Dunner K; Benedict WF
    Cancer Gene Ther; 2010 Aug; 17(8):579-84. PubMed ID: 20489789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect.
    Zhang X; Dong L; Chapman E; Benedict WF
    Cancer Gene Ther; 2008 Dec; 15(12):817-22. PubMed ID: 18617914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.
    Fisher MB; Zhang XQ; McConkey DJ; Benedict WF
    Cancer Gene Ther; 2009 Jul; 16(7):567-72. PubMed ID: 19197325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
    Adam L; Black PC; Kassouf W; Eve B; McConkey D; Munsell MF; Benedict WF; Dinney CP
    J Urol; 2007 May; 177(5):1900-6. PubMed ID: 17437845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells.
    Papageorgiou A; Lashinger L; Millikan R; Grossman HB; Benedict W; Dinney CP; McConkey DJ
    Cancer Res; 2004 Dec; 64(24):8973-9. PubMed ID: 15604261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
    Hirata T; Watanabe M; Kaku H; Kobayashi Y; Yamada H; Sakaguchi M; Takei K; Huh NH; Nasu Y; Kumon H
    Int J Oncol; 2012 Aug; 41(2):559-64. PubMed ID: 22665039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.
    Nagabhushan TL; Maneval DC; Benedict WF; Wen SF; Ihnat PM; Engler H; Connor RJ
    Cytokine Growth Factor Rev; 2007; 18(5-6):389-94. PubMed ID: 17692556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation.
    Yang Z; Zhang XQ; Dinney CN; Benedict WF
    Cancer Gene Ther; 2011 Sep; 18(9):609-16. PubMed ID: 21681220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.
    Tao Z; Connor RJ; Ashoori F; Dinney CP; Munsell M; Philopena JA; Benedict WF
    Cancer Gene Ther; 2006 Feb; 13(2):125-30. PubMed ID: 16082384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA
    Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
    Shariat SF; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster BA; Greenberg N; Spencer DM; Slawin KM
    Cancer Res; 2001 Mar; 61(6):2562-71. PubMed ID: 11289132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
    Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retinoic acid and interferon alpha-2a on transitional cell carcinoma of bladder.
    Zou C; Ramakumar S; Qian L; Zou C; Zang R; Wang J; Grossman HB; Lotan R; Liebert M
    J Urol; 2005 Jan; 173(1):247-51. PubMed ID: 15592090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.
    Ohashi M; Yoshida K; Kushida M; Miura Y; Ohnami S; Ikarashi Y; Kitade Y; Yoshida T; Aoki K
    Br J Cancer; 2005 Aug; 93(4):441-9. PubMed ID: 16106250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
    Tai YT; Strobel T; Kufe D; Cannistra SA
    Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.